about
Botulinum toxinBotulinum toxin dilution: our technique.The anti-wrinkle efficacy of Argireline.Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin aThe C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.Effects of a botulinum toxin type A injection on the masseter muscle: An animal model studyBotulinum toxin for the treatment of hyperfunctional lines of the forehead.Botulinum toxin - an update on its use in facial rejuvenation.Use of Botulinum Neurotoxin in Ophthalmology.Botox as an adjunct to lip repositioning for the management of excessive gingival display in the presence of hypermobility of upper lip and vertical maxillary excess.Management of gummy smile with Botulinum Toxin Type-A: A case report.Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.Botulinum toxin type a for the treatment of hyperkinetic lines of the face.Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles.The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study.In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation.Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines.Botulinum toxin type A for aging face and aesthetic uses.Variability of Botulinum Toxins: Challenges and Opportunities for the Future
P2860
Q24634441-050C363D-AA3A-4FBC-AEED-203F5B1F1424Q31037780-B099FB80-4C07-40DB-A0FC-5E3DAAB0F698Q34609979-8345BC33-E5C6-47A9-92E4-2072F32B2A9DQ34995583-1713F344-9647-44BE-911F-F0C25EA19C19Q35187559-3C647A79-F1EB-4A58-8C55-486A0673CCEAQ35530101-8CAAAAAB-E699-483F-8089-C4C676801B2AQ35990412-E8C40A68-D45A-418D-8B88-79A52B5CC53BQ36683949-343EC694-C24E-4A9B-AF59-C3E77F5849F2Q37525827-BDF0DA06-5B09-4AEC-BA05-2DD5863D11BBQ37599319-2DC50DB7-01F4-486B-9C0A-1D0D83751C2DQ37646494-73BCC3F7-E625-4BE0-A988-4A797995C694Q37700722-494A9DFF-2F32-4122-A5A9-84AC32BB947EQ42015289-9C6D0C5A-5433-4024-9641-C468DAB72A8AQ43579387-DFE7F3AF-8E96-4459-B9D0-C3FACFC1D9D1Q44188990-21FB502A-7638-42CC-B0E0-88E95886735CQ46035855-22DFCDAA-716A-4AE0-8C12-F59D80267F4CQ46812210-881CA18A-CA7D-4CBE-9026-3C253DC55EECQ53052703-2DBDA331-78FC-4AD6-A576-2C0071735124Q57157766-7D9DBCE6-FCA7-4D7E-AD1D-13AABEADE594
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The cosmetic uses of Botulinum toxin type A.
@ast
The cosmetic uses of Botulinum toxin type A.
@en
type
label
The cosmetic uses of Botulinum toxin type A.
@ast
The cosmetic uses of Botulinum toxin type A.
@en
prefLabel
The cosmetic uses of Botulinum toxin type A.
@ast
The cosmetic uses of Botulinum toxin type A.
@en
P2860
P1476
The cosmetic uses of Botulinum toxin type A.
@en
P2093
Benedetto AV
P2860
P304
P356
10.1046/J.1365-4362.1999.00722.X
P577
1999-09-01T00:00:00Z